犬 B7-H3-CAR.CIK 淋巴细胞抗肉瘤的开发与活性：临床前证据及向人类临床转化的前景
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.
我们成功制备了犬 B7-H3-CAR.CIK，平均 CAR 表达率为 39% ± 2，免疫表型与未转导（NTD）对照相比未发生改变（CD3 = 92% ± 3，CD8 = 87% ± 7；CD4 = 49% ± 5；CD5 = 77% ± 0.1；NKp46 = 83% ± 5）。
55.5分
★★★☆☆
站内排序·非疗效